Results 11 to 20 of about 13,710 (215)

Evaluation of Levonorgestrel Subdermal Implant as Long Term Reversible Contraceptive [PDF]

Journal of Rawalpindi Medical College, 2018
Background: To study the reasons of acceptability, efficacy,short term and long term side effects of Levonorgestrel Subdermal implant as long term reversible contraceptive.
Taqdees Iftikhar, Jehan Ara, Humaira Arshad, Nadra Sultana   +3 more
doaj   +2 more sources

CONTRACEPCION DE EMERGENCIA: EFECTO POSTFERTILIZACION DEL LEVONORGESTREL

Revista Chilena de Obstetricia y Ginecología, 2003
Para las paciente y médicos que creen que la persona humana comienza su existencia con la fertilización, los métodos de planificación familiar que actúan interrumpiendo el desarrollo embrionario en sus primeras etapas no son éticamente aceptables.
Maritza Busquets C.
doaj   +2 more sources

Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: An economic evaluation alongside a randomised controlled trial [PDF]

, 2014
Objective: To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ('LNG-IUS') and usual medical treatment for women with menorrhagia in primary care; and compare the ...
Lee Middleton, Kai, J, Middleton, Lee; id_orcid, Kai, Joe, Daniels Jane, Middleton, Lee, Frew, Emma, Middleton Lee, Tracy Elizabeth Roberts, Pelham Barton, Janesh Kumar Gupta, Frew Emma, Sanghera Sabina, Laura Gennard, Gennard, Laura, Jane Daniels, Emma Frew, Barton, Pelham, Barton, P, Daniels, J, Sanghera, S, Sabina Sanghera, Kai Joe, Gennard, L, Joe Kai, Middleton, L, Roberts, Tracy Elizabeth, Roberts Tracy Elizabeth, Barton Pelham, Frew, E, Gupta, Janesh Kumar, Gupta, Janesh, Roberts, TE, Sanghera, Sabina, Gupta Janesh Kumar, Frew, Emma; id_orcid, Daniels, Jane, Gupta, JK, Gennard Laura   +38 more
core   +1 more source

Non-contraceptive applications of the levonorgestrel intrauterine system [PDF]

, 2010
Maria Isabel Rodriguez, Philip D DarneyDepartment of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital and Bixby Center for Global Reproductive Health, University of California, San Francisco, CA, USAAbstract: Intrauterine
Maria Isabel Rodriguez, Darney, Philip D, Philip D Darney, Philip Darney, Rodriguez, Maria Isabel, null Rodriguez   +5 more
core   +1 more source

The use of emergency hormonal contraception in South Africa: current and future perspectives

South African Family Practice, 2019
Emergency hormonal contraceptives play an important role in preventing unplanned pregnancies in South Africa. In this review, we discuss the levonorgestrel emergency contraceptive, the combined estrogen and progestin regimen (also known as the Yuzpe ...
N. Dahan-Farkas, M. Vally
doaj   +1 more source

Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial [PDF]

, 2020
OBJECTIVES: Our primary objective was to compare geometric mean levonorgestrel concentrations between levonorgestrel implant users who were or were not taking the antiretroviral efavirenz, for up to 30 months after implant initiation.
Corbett, Amanda H., Cottrell, Mackenzie L., Davis, Nicole L., Chinula, Lameck, Hosseinipour, Mina C., Tang, Jennifer H., Kourtis, Athena P., Haddad, Lisa B., Tegha, Gerald, Stanczyk, Frank Z., Zia, Yasaman, Hurst, Stacey   +11 more
core   +1 more source

Pharmacodynamic surrogates of levonorgestrel activity.

, 2022
Pharmacodynamic surrogates of levonorgestrel activity.
Nazita Yousefieh (751094), Betsy C. Herold (9634748), Leila Cochon (12621924), Elizabeth Tolley (5945897), Andrea R. Thurman (5286005), Vivian Brache (200187), Melissa Peet (13933074), Urvi Parikh (346278), Jill L. Schwartz (11434312), Susan Ju (5940782), Louise A. Ouattara (12210068), Gustavo F. Doncel (339755), Raina N. Fichorova (7251227), David W. Erikson (13933077), Homaira Hanif (10885137), Meredith R. Clark (11434306), Terry Jacot (5940767), Mark A. Marzinke (9579575), Neelima Chandra (5465411)   +18 more
core   +1 more source

Seguridad y aceptabilidad del sistema intrauterino liberador de levonorgestrel 52 mg en mujeres con hemorragia uterina anormal en un centro de atención ambulatoria en Bogotá, Colombia, 2012-2016

Revista Colombiana de Obstetricia y Ginecología, 2020
Objetivo: describir la seguridad y aceptabilidad del uso del sistema intrauterino liberador de levonorgestrel de 52 mg en mujeres con hemorragia uterina anormal. Materiales y métodos: cohorte retrospectiva en la que se incluyeron mujeres de 18 años o más
Patricia Sandoval-Vivas
doaj   +1 more source

Changes of Body Mass Index and Lipid Profile in Injectable Depot Medroxyprogesterone Acetate and Levonorgestrel Implant Acceptors

Indonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone ...
Irwan Daido, Andi M Tahir, St Maisuri T Chalid   +2 more
doaj   +1 more source

Farmacêuticos alertam: Automedicação do Levonorgestrel e seus efeitos colaterais / Pharmacist’s alert: Self-medication of Levonorgestrel and its side effects [PDF]

, 2021
INTRODUÇÃO: O tema da contracepção de emergência Levonorgestrel é aqui estudado porque o mesmo tem a ver com o risco de engravidar e com o sexo desprotegido. No meio científico/acadêmico, o Levonorgestrel também é conhecido como “pílula do dia seguinte”,
Vasconcelos, Alyne Braga da Silva, de Oliveira, Maria Isabel Araújo, Lima, Jaqueline Chaves, Brito, Marcelo Augusto Mota, Romão, Franciele Araújo   +4 more
core   +1 more source